J. Ives

1.5k total citations
10 papers, 1.1k citations indexed

About

J. Ives is a scholar working on Epidemiology, Virology and Molecular Biology. According to data from OpenAlex, J. Ives has authored 10 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 3 papers in Virology and 2 papers in Molecular Biology. Recurrent topics in J. Ives's work include Herpesvirus Infections and Treatments (6 papers), Cytomegalovirus and herpesvirus research (6 papers) and Influenza Virus Research Studies (3 papers). J. Ives is often cited by papers focused on Herpesvirus Infections and Treatments (6 papers), Cytomegalovirus and herpesvirus research (6 papers) and Influenza Virus Research Studies (3 papers). J. Ives collaborates with scholars based in United Kingdom, United States and Canada. J. Ives's co-authors include N. A. Roberts, Dirk B. Mendel, Rob Lambkin‐Williams, Lauren E. Kelly, Frederick G. Hayden, C. Y. Tai, John Oxford, Jeffrey D. Punch, I.A. Hauser and Ajit P. Limaye and has published in prestigious journals such as The Journal of Infectious Diseases, American Journal of Transplantation and Antiviral Research.

In The Last Decade

J. Ives

9 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Ives United Kingdom 9 1.0k 211 178 129 98 10 1.1k
Sébastien Hantz France 17 583 0.6× 277 1.3× 73 0.4× 105 0.8× 7 0.1× 75 873
Abel E. Vásquez Chile 10 169 0.2× 188 0.9× 87 0.5× 14 0.1× 8 0.1× 25 556
Michael Carpenter Canada 11 199 0.2× 264 1.3× 117 0.7× 19 0.1× 2 0.0× 19 594
Daisy Ko United States 9 301 0.3× 279 1.3× 165 0.9× 43 0.3× 12 0.1× 16 596
Randall Lanier United States 16 452 0.4× 347 1.6× 259 1.5× 85 0.7× 4 0.0× 31 814
Bettina M. Knoll United States 12 169 0.2× 248 1.2× 125 0.7× 123 1.0× 11 0.1× 22 539
Knut Ivan Kristiansen Norway 15 165 0.2× 92 0.4× 146 0.8× 38 0.3× 20 0.2× 20 512
Jean-Louis Bresson France 9 335 0.3× 247 1.2× 163 0.9× 9 0.1× 7 0.1× 13 660
Andrea Stossel United States 8 305 0.3× 552 2.6× 116 0.7× 127 1.0× 4 0.0× 9 738
Julie Carbonneau Canada 18 783 0.8× 453 2.1× 141 0.8× 27 0.2× 2 0.0× 57 1.1k

Countries citing papers authored by J. Ives

Since Specialization
Citations

This map shows the geographic impact of J. Ives's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Ives with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Ives more than expected).

Fields of papers citing papers by J. Ives

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Ives. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Ives. The network helps show where J. Ives may publish in the future.

Co-authorship network of co-authors of J. Ives

This figure shows the co-authorship network connecting the top 25 collaborators of J. Ives. A scholar is included among the top collaborators of J. Ives based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Ives. J. Ives is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
2.
3.
Chou, Sunwen, Guy Boivin, J. Ives, & Robert C. Elston. (2013). Phenotypic Evaluation of Previously Uncharacterized Cytomegalovirus DNA Polymerase Sequence Variants Detected in a Valganciclovir Treatment Trial. The Journal of Infectious Diseases. 209(8). 1219–1226. 24 indexed citations
4.
Humar, Atul, Y Lebranchu, Flavio Vincenti, et al.. (2010). The Efficacy and Safety of 200 Days Valganciclovir Cytomegalovirus Prophylaxis in High‐Risk Kidney Transplant Recipients. American Journal of Transplantation. 10(5). 1228–1237. 366 indexed citations
5.
Humar, Abhi, Y Lebranchu, Flavio Vincenti, et al.. (2009). The IMPACT Study: Valganciclovir Prophylaxis for until 200 Days Post-Transplant in High Risk Kidney Recipients Substantially Reduces the Incidence of CMV Disease.. Ghent University Academic Bibliography (Ghent University). 10 indexed citations
6.
Pescovitz, Mark D., Robert B. Ettenger, C. Frederic Strife, et al.. (2009). Pharmacokinetics of oral valganciclovir solution and intravenous ganciclovir in pediatric renal and liver transplant recipients. Transplant Infectious Disease. 12(3). 195–203. 48 indexed citations
7.
Varela‐Fascinetto, Gustavo, et al.. (2009). Valganciclovir Dosing According to Body Surface Area and Renal Function in Pediatric Solid Organ Transplant Recipients. American Journal of Transplantation. 9(3). 636–643. 81 indexed citations
8.
Herlocher, M. Louise, et al.. (2002). Influenza virus carrying an R292K mutation in the neuraminidase gene is not transmitted in ferrets. Antiviral Research. 54(2). 99–111. 124 indexed citations
9.
Ives, J., Lauren E. Kelly, Rob Lambkin‐Williams, et al.. (2002). Influenza virus carrying neuraminidase with reduced sensitivity to oseltamivir carboxylate has altered properties in vitro and is compromised for infectivity and replicative ability in vivo. Antiviral Research. 54(2). 79–88. 154 indexed citations
10.
Ives, J., Dirk B. Mendel, C. Y. Tai, et al.. (2002). The H274Y mutation in the influenza A/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo. Antiviral Research. 55(2). 307–317. 300 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sébastien Hantz Breakdown of academic impact, for papers by Abel E. Vásquez Breakdown of academic impact, for papers by Michael Carpenter Breakdown of academic impact, for papers by Daisy Ko Breakdown of academic impact, for papers by Randall Lanier Breakdown of academic impact, for papers by Bettina M. Knoll Breakdown of academic impact, for papers by Knut Ivan Kristiansen Breakdown of academic impact, for papers by Jean-Louis Bresson Breakdown of academic impact, for papers by Andrea Stossel Breakdown of academic impact, for papers by Julie Carbonneau
Rankless by CCL
2026